Atıf Formatları
SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. Aptullahoglu Et Al. , "SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.," International journal of molecular sciences , vol.24, no.14, 2023

Aptullahoglu, E. Et Al. 2023. SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.. International journal of molecular sciences , vol.24, no.14 .

Aptullahoglu, E., Wallis, J. P., Marr, H., Marshall, S., Bown, N., Willmore, E., ... Lunec, J.(2023). SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.. International journal of molecular sciences , vol.24, no.14.

Aptullahoglu, ERHAN Et Al. "SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.," International journal of molecular sciences , vol.24, no.14, 2023

Aptullahoglu, ERHAN Et Al. "SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.." International journal of molecular sciences , vol.24, no.14, 2023

Aptullahoglu, E. Et Al. (2023) . "SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.." International journal of molecular sciences , vol.24, no.14.

@article{article, author={ERHAN APTULLAHOĞLU Et Al. }, title={SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.}, journal={International journal of molecular sciences}, year=2023}